Novartis is entering a new phase of growth powered by blockbuster cancer medicines, radioligand therapy innovation, and precision oncology expansion. […]
The global pharmaceutical CXO industry is no longer driven only by large drug companies. Behind many blockbuster medicines, vaccines, biologics,
Gilead Sciences Is Expanding Aggressively Beyond Traditional Oncology Gilead Sciences remains one of the strongest revenue generators in oncology cell
The biotechnology industry has moved far beyond traditional pharma. Today, it is a high-tech ecosystem powered by gene editing, mRNA
The pharmaceutical industry in 2025–2026 is increasingly being shaped by a “winner-takes-most” innovation cycle, where a small group of high-impact
Cell & Gene Therapy in 2026 is no longer an experimental corner of biotechnology.It is rapidly becoming a large-scale industrial
The U.S. host cell proteins (HCPs) analysis market is growing steadily, yet quietly shaping the backbone of biopharmaceutical safety. Valued
South America life science analytical instruments market is expanding in a quiet but consistent way.It reached $1.78 billion in 2024
The automated blood processing equipment market is steadily transforming modern healthcare systems.Valued at US$ 2.12 billion in 2024, the market
The global medical engineered materials market stood at USD 29.15 billion in 2025.It is expected to grow to USD 32.95